BioCentury
ARTICLE | Financial News

Aequus Pharmaceuticals completes follow-on

March 15, 2017 7:54 PM UTC

Neurology, ophthalmic and transplant company Aequus Pharmaceuticals Inc. (TSX-V:AQS; OTCQB:AQSZF) raised C$5.2 million ($3.8 million) through the sale of 17.3 million units at C$0.30 in a bought deal...

BCIQ Company Profiles

Aequus Pharmaceuticals Inc.